SCHEMBL23347102

SCHEMBL23347102

c1cc2c3c(cccc3c1)-c1cc3c(cc1-2)c(-c1cccc2sc4ccccc4c12)cc1c2cc4c(cc2c(-c2cccc5sc6ccccc6c25)cc31)-c1cccc2cccc-4c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 4/20 0.48
MAPK1 P28482 4/20 0.48
HPGD P15428 4/20 0.48
TSHR P16473 3/20 0.48
CASP1 P29466 3/20 0.48
HIF1A Q16665 2/20 0.48
CASP7 P55210 2/20 0.48
TP53 P04637 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 2/20 0.44
GPR3 P46089 1/20 0.41
BRDT Q58F21 1/20 0.40
ALOX5 P09917 1/20 0.37
CYP3A4 P08684 1/20 0.37
PABPC1 P11940 1/20 0.37
DNMT1 P26358 1/20 0.37
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23347119 0.92 ALDH1A1 (0.45) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL23347147 0.89 ALDH1A1 (0.39) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL18907473 0.87 GPR3 (0.41) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL18907536 0.87 ALDH1A1 (0.51) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL23347323 0.84 ALOX5 (0.51) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL23347021 0.84 CARM1 (0.39) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL16553298 0.82 GPR3 (0.59) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL30550557 0.82 GPR3 (0.59) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL22927417 0.82 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL23347315 0.82 ALOX5 (0.46) ALDH1A1HSD17B10MAPK1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844268-B2 Organic compound and organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2023-12-12 US disclosed
US-11844268-B2 Organic compound and organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2023-12-12 US disclosed
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11844268-B2 Organic compound and organic light-emitting element OR51E2, OR10J3, NR2E3 ALDH1A1 151/4885HSD17B10 560/4885MAPK1 2818/4885
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT OR51E2, OR10J3, NR2E3 ALDH1A1 151/4885HSD17B10 560/4885MAPK1 2818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.